Journal of Dermatology and Dermatologic Surgery (Jan 2023)
A 60-week real-world experience with guselkumab in patients with moderate-to-severe plaque psoriasis including patients with malignancy: A retrospective study from Ontario, Canada
Abstract
No abstracts available.